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Digital interventions to promote self-management
in adults with hypertension systematic review
andmeta-analysis
Gary McLeana, Rebecca Bandb, Kathryn Saundersona, Peter Hanlona, Elizabeth Murrayc,
Paul Littled, Richard J. McManuse, Lucy Yardleyb, Frances S. Maira, on behalf of the
DIPSS co-investigators
Objective: To synthesize the evidence for using
interactive digital interventions (IDIs) to support patient
self-management of hypertension, and to determine
their impact on control and reduction of blood
pressure.
Method: Systematic review with meta-analysis was
undertaken with a search performed in MEDLINE,
EMBASE, CINAHL, PsycINFO, ERIC, Cochrane Library,
DoPHER, TROPHI, Social Science Citation Index and
Science Citation Index. The population was adults
(>18 years) with hypertension, intervention was an
IDI and the comparator was usual care. Primary outcomes
were change in SBP and DBP. Only randomized controlled
trials and studies published in journals and in English were
eligible. Eligible IDIs included interventions accessed
through a computer, smartphone or other hand-held
device.
Results: Four out of seven studies showed a significantly
greater reduction for intervention compared to usual care
for SBP, with no difference found for three. Overall, IDIs
significantly reduced SBP, with the weighted mean
difference being 3.74mmHg [95% confidence
interval (CI) 2.19 to 2.58] with no heterogeneity
observed (I-squared¼0.0%, P¼0.990). For DBP, four
out of six studies indicated a greater reduction for
intervention compared to controls, with no difference
found for two. For DBP, a significant reduction of
2.37mmHg (95% CI 0.40 to 4.35) was found, but
considerable heterogeneity was noted (I-squared¼80.1%,
P¼<0.001).
Conclusion: IDIs lower both SBP and DBP compared
to usual care. Results suggest these findings can be
applied to a wide range of healthcare systems and
populations. However, sustainability and long-term
clinical effectiveness of these interventions remain
uncertain.
Keywords: blood pressure, digital intervention,
hypertension
Abbreviations: CVD, cardiovascular disease; IDIs,
interactive digital interventions; NHS, National Health
Service; RCTs, randomized controlled trials
INTRODUCTION
H
ypertension is a chronic medical condition in
which the blood pressure of the arteries is elevated,
and is normally defined as beingwhen SBP is above
140mmHg and/or DBP is above 90mmHg (http://www.
nice.org.uk/nicemedia/live/13561/56015/56015.pdf). Hy-
pertension has the highest attributable risk for death from
cardiovascular disease (CVD), which is the leading cause of
premature morality worldwide [1]. Clinically significant
effects and improvements in mortality can be achieved with
relatively small reductions in blood pressure levels [2,3].
However, the rate of control and treatment of hypertension
is poor, with a large gap found between the detection and
control of hypertension [4]. In addition, hypertension is an
asymptomatic condition and medications may cause
unpleasant side effects, exacerbating adherence problems
[5]. Consequently, alternative strategies to promote blood
pressure control are needed.
Guided self-management for hypertension as part of
systematic, planned care offers the potential for improve-
ments in adherence and in turn improved long-term patient
outcomes. Self-management can encompass a wide range of
behaviours in addition to medication titration and monitor-
ing of symptoms, such as individuals’ ability to manage
physical, psychosocial and lifestyle behaviours related to
their condition [6]. Self-management in hypertension,
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including self-titration and behavioural interventions, has
been shown to be effective [7,8].
Despite evidence of benefits, guided self-management
and education in the control of hypertension remain under-
used [9]. Interactive digital interventions (IDIs) can play a
crucial role in meeting National Health Service (NHS) policy
aims to empower patients to self-manage their long-term
conditions, providing patients with better access to person-
alized information and support for active involvement in
treatment, as well as producing significant savings in treat-
ment costs. They are web-based packages delivered by
computer or phone that can combine health information
with decision support and help inform behaviour change in
patients. IDIs can potentially improve the efficiency of
healthcare by automating routine aspects of patient edu-
cation,monitoring and support,whilst improving services by
giving patients convenient 24-h access to detailed, person-
alized feedback and allowing health professionals to
remotely monitor patient status [10,11]. There is clear evi-
dence that well designed IDIs can effectively change patient
health-related behaviour, improve patient knowledge and
confidence for self-management of health and lead to better
health outcomes [12,13]. A recent systematic review and
meta-analysis on the impact of digital interventions on
CVD outcomes found that IDIs significantly reduced CVD
outcomes, weight and BMI, but not blood pressure [14].
Therefore, there is growing interest in the potential of the
internet and other digital media as a medium to deliver
more tailored, relevant self-management support, while
maintaining cost-effectiveness, in support of those with
hypertension. There have been a number of reviews which
have examined the impact of self-monitoring in adults with
hypertension [15–17] while Liu et al. [18] assessed the
impact of the internet on blood pressure control assessing
both RCTs and case-control studies. However, we are not
aware of any reviews which focus on RCTs for self-manage-
ment IDIs in those with hypertension and compare with
usual care only. Therefore this systematic review aims to
synthesize the evidence for using IDIs to support patient
self-management of hypertension, and determine their
impact on control and reduction of blood pressure, other
clinical outcomes, quality of life, medication adherence and
economic benefits.
METHODS
Design: systematic review and meta-analysis
A registered protocol (PROSPERO CRD42013004773)
guided the conduct of this review [19], which we reported
in adherence to the Preferred Reporting Items for System-
atic Reviews and Meta-analyses (PRISMA) Statement [20].
Eligibility criteria
Inclusion criteria were based on the PICOS acronym
(http://library.med.nyu.edu/library/instruction/handouts/
pdf/picohandout.pdf)]: the population was adults (18 years
and over) with hypertension (as defined by the primary
authors); the intervention was an IDI (as defined below);
the comparator was usual care; outcomes must include
objectively measured change in blood pressure (SBP or
DBP); only randomized controlled trials (RCTs) were
included as they present the strongest level of evidence;
we only considered studies published in journals and in
English as evidence suggests that limiting studies in this way
does not introduce significant bias [21].
For the purpose of this review, the term IDI will include
any intervention accessed through a computer (work or
home), or smartphone, or other hand-held device, and
include web-based programs, desktop computer programs
or apps that provide self-management information and can
be used on or offline. The intervention must function
without the need for directive input from a health pro-
fessional. They must also be ‘interactive’, which we define
as requiring contributions from program users (e.g. enter-
ing personal data, making choices), which alter pathways
within programs to produce tailored material and feedback
that is personally relevant to users.
Information sources and search strategy
Searches were undertaken by a professional systematic
review company – the York Health Economic Consortium
(http://www.yhec.co.uk/.). The strategies were informed
by the intervention search terms used in a previous system-
atic review conducted by the team on digital asthma
self-management interventions [22]. The search strategy
combined three concepts and a study type filter for RCTs:
1. Hypertension (lines 1–11 of search strategy)
2. Digital interventions (lines 12–71)
3. RCTs (lines 73–80)
The following databases were searched: MEDLINE,
EMBASE, CINAHL, PsycINFO, ERIC, Cochrane Library
(including CDSR, DARE, Central, NHS EED and HTA data-
bases), DoPHER and TROPHI (both produced by the EPPI
Centre), Social Science Citation Index and Science Citation
Index. These databases were searched using a combination
of subject headings when available (such as MeSH) and
words in the title and abstracts.
The search was complemented by contacting experts in
the topic under review, and by carrying out citation
searches for articles which cite individual studies that are
included in the review [23].
Study selection
All abstracts identified from the search were downloaded
following de-duplication into the Distiller software pro-
gram [24]. Abstracts and full papers that met the inclusion
criteria were screened by two reviewers working independ-
ently. Inter-reviewer disagreements were resolved by seek-
ing consensus between the reviewers or, if this was not
possible, the decision was referred to the steering group.
Outcome measures are listed in Table 1 with the primary
outcomes being changes in mean SBP and DBP, and
quality-of-life indicators.
Data extraction
We used online data collection forms using Distiller SR
software. Data were extracted on study details (country of
origin, inclusion/exclusion criteria, number of partici-
pants), participant details (mean age, % male, ethnicity,
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socio-economic, smoking and comorbidities), intervention
details (description, theoretical basis, setting, duration,
intensity and format) and outcomes including mean change
in SBP and DBP, any other clinical outcome changes,
behavioural (medication adherence, dietary change, levels
of physical change), cognitive (knowledge of condition,
satisfaction with care), affective (change in depressive or
anxiety levels) and economic (cost-effectiveness).
Assessment of methodological quality
Risk of bias was assessed in each of the included studies by
the two researchers working independently using the
Cochrane collaboration tool for assessing bias for guidance
[25]. Methods of allocation concealment, randomization
procedure, dropout rate and whether there was evidence
of selective outcome reporting were assessed.
Analysis
Analysis of interventions
Meta-analysis was based on guidelines from the Cochrane
Handbook for Systematic Reviews of Interventions [26].
Potential publication bias was assessed by using a funnel
plot and Egger’s test [27]. We used a random-effects model
for the meta-analysis of the difference in mean change in
mmHg for SBP and DBP and kilogram for weight.
A random-effect model was used due to the wide variation
of the included studies both in terms of the population
characteristics (age, sex), and also mean SBP and DBP
levels at baseline. When SD of the change was not reported,
we estimated the SD using confidence intervals (CIs) or
p-scores. We divided studies into two groups – those that
contained self-monitoring of blood pressure and those that
did not – and reported for both groups and overall.
Heterogeneity statistics were assessed by the Q statistic
and I-squared statistics [28].
RESULTS
Our search identified 5606 papers; after abstract screening
there were 164 papers for full paper review. Eight papers
from seven interventionsmet our criteria andwere included
(Fig. 1).
M
E
D
L
IN
E
 a
nd
 M
E
D
L
IN
E
 In
-p
ro
ce
ss
N
o
 d
at
e 
lim
it
-2
01
4
19
16
 C
it
at
io
n
(s
) 
E
M
B
A
S
E
N
o
 d
at
e 
lim
it
-2
01
4
17
17
 C
it
at
io
n
(s
)
C
IN
A
H
L
 P
lu
s
N
o
 d
at
e 
lim
it
-2
01
4
I I
22
 C
it
at
io
n
(s
)
P
sy
cI
N
F
O
N
o
 d
at
e 
lim
it
-2
01
4
39
5 
C
it
at
io
n
 (
s)
C
E
N
T
R
A
L
N
o
 d
at
e 
lim
it
-2
01
4
17
89
 C
it
at
io
n
(s
)
S
S
C
I
N
o
 d
at
e 
lim
it
-2
01
4
13
14
 C
it
at
io
n
(s
)
56
06
 N
on
-D
up
lic
at
e
C
it
at
io
ns
 S
cr
ee
ne
d
In
cl
us
io
n
/e
xc
lu
si
on
cr
it
er
ia
 a
pp
lie
d
16
2 
A
rt
ic
le
s 
re
tr
ie
ve
d
In
cl
us
io
n
/e
xc
lu
si
on
cr
it
er
ia
 a
pp
lie
d
8 
A
rt
ic
le
s 
In
cl
ud
ed
 w
it
h
 S
B
P
 7
,D
B
P
 6
, w
ei
gh
t 2
,c
ho
le
st
er
ol
 2
,m
ed
ic
at
io
n
 a
dh
er
en
ce
 3
, m
en
ta
l h
ea
lt
h
 1
, s
at
is
fa
ct
io
n
 w
it
h
 
ca
re
 e
ff
ec
ti
ve
ne
ss
 I
15
4 
A
rt
ic
le
s 
ex
cl
ud
ed
af
te
r 
fu
ll 
 t
ex
t s
cr
ee
n
0 
A
rt
ic
le
s 
ex
cl
ud
ed
du
ri
ng
 d
at
a 
ex
tr
ac
ti
on
54
44
 A
rt
ic
le
s 
ex
cl
ud
ed
A
ft
er
 t
it
le
/a
bs
tr
ac
t s
cr
ee
n
E
R
IC
N
o
 d
at
e 
lim
it
-2
01
4
88
 C
it
at
io
n
(s
)
C
D
S
R
N
o
 d
at
e 
lim
it
-2
01
4
88
 C
it
at
io
n
(s
)
D
A
R
E
N
o
 d
at
e 
lim
it
-2
01
4
18
1 
C
it
at
io
n
(s
)
H
TA
N
o
 d
at
e 
lim
it
-2
01
4
8 
C
it
at
io
n
(s
)
D
o
P
H
E
R
N
o
 d
at
e 
lim
it
-2
01
4
25
 C
it
at
io
n
(s
)
T
R
O
P
H
I
N
o
 d
at
e 
lim
it
-2
01
4
45
 C
it
at
io
n
(s
)
FI
G
U
R
E
1
PR
IS
M
A
fl
o
w
ch
ar
t.
PR
IS
M
A
,
Pr
ef
er
re
d
R
ep
o
rt
in
g
It
em
s
fo
r
Sy
st
em
at
ic
R
ev
ie
w
s
an
d
M
et
a-
an
al
ys
es
.
TABLE 1. Types of outcome measures
Outcome measure
description
Primary
outcome
Secondary
outcome
Clinical Mean SBP and DBP
Clinical Quality-of-life indicators
Cognitive Self-efficacy
Behavioural Medication adherence
Behavioural Dietary change
Behavioural Physical activity
Affective Depression
Affective Anxiety
Affective Emotional well being
Affective Satisfaction with care
Economic Health service utilisation
Economic Costs of intervention
McLean et al.
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Description of included studies
The seven studies included a total of 1259 participants, with
a range of 35–387 participants per study (Table 1). Three
studies had been undertaken in the United States [29–32],
and one each in Korea [33], Honduras and Mexico [34],
Canada [35], and Finland [36]. The studies varied consider-
ably in the nature and delivery of the intervention, the study
population and the outcome measures used.
Description of interventions
A summary of the key components of the interventions are
given in Table 2.
Aim of intervention
Five of the interventions had reducing blood pressure as a
main objective. For Bennett et al. [29], the main objective
was weight loss, but blood pressure was included as a
secondary objective. In the study by Orsma et al. [36], the
main focus was to improve self-management and health
status in patients with type 2 diabetes, but improvements in
blood pressure were also included as a primary aim.
Format and delivery
Mobile phone was the most common mode of delivery in
the studies conducted by Yoo et al. [33], Piette et al. [34] and
Orsma et al. [36]. Watson et al. [32] used a website in which
participants after uploading blood pressure readings
through a communications device by phone could view
trends and read automated rules-based messages. Nolan
et al. [35] used a series of e-mails to deliver their interven-
tion, whereas Bennett et al. [29] offered the choice to
participants of using either the study website or an inter-
active voice response system to monitor their progress.
Friedman et al. [31] used a telephone linked computer
system which spoke to patients over the telephone using
computer-controlled speech. The patients communicated
using the touch-tone keypad on their telephones.
Education
All of the studies provided additional education via the
intervention. This was poorly described in some and ranged
from providing tailored behavioural skills training
materials, including tailored information on community
resources (e.g. public parks, walking groups and farmers’
markets) and distributing a walking kit to a simple menu
that linked to educational material and self-help tips for
lifestyle change [34].
Additional health professional help available
Three of the studies specified that additional health
professional help could be accessed through the inter-
vention if participants required it. Yoo et al. [33] allowed
physicians to use the intervention website to follow
participants’ trends in blood glucose levels, blood pres-
sure and body weight changes, and then send individu-
alized recommendations to patients when needed. In the
study by Orsma et al., nurses scanned through the status
of all intervention patients each week and contacted
patients if warranted by their remote data reports. For
the study by Bennett et al. [29], trained community health
educators delivered counselling calls monthly during the
first 12 months of intervention and bimonthly during the
second year. No difference was found in blood pressure
reduction between those offering additional help and
those not, for either SBP (additional help 3.37, 95% CI
0.22 to 6.52 vs. no additional help3.85, 95% CI2.08
to 563) or DBP (additional help 2.18, 95% CI 0.45 to
3.91 vs. no additional help 2.58, 95% CI 0.95 to 6.11)
(see supplementary Figs 1 and 2, http://links.lww.com/
HJH/A580.
Setting
Five of the studies were set in healthcare settings, ranging
from a hospital and community healthcare site to outpatient
clinics. One study was based in three worksites and one
used a number of community sites.
Duration and intensity
Only the study by Bennett et al. [29] (with a duration of
24 months) lasted longer than 10 months, with the shortest
duration being 6 weeks [33]. No significant difference was
found when comparing interventions by duration for SBP
(6 months or longer 4.35, 95% CI 2.10 to 6.60 vs. less
than 6 months 3.19, 95% CI 1.07 to 5.32) or DBP
(6 months or longer 3.16, 95% CI 0.83 to 6.49 vs. less
than 6 months 3.94, 95% CI 0.37 to 3.35; see supple-
mentary Figs 3 and 4, http://links.lww.com/HJH/A580).
Intensity of intervention ranged from daily use in three
studies to weekly use in two studies. Bennett et al. [29] had
no specific rate of intervention use, whereas Nolan et al.
[35] reduced intensity of use over the duration of the
intervention, from daily in the first month to biweekly
in month 2 and weekly in months 3 and 4. No significant
difference was found for SBP when comparing those
interventions which required daily use (2.73, 95%
CI 0.35 to 5.12) vs. other intervention (4.46, 95%
CI 2.44 to 6.49), but daily use interventions had a
significantly lower reduction for DBP (daily use 1.29,
95% CI 0.04 to 2.53 vs. other interventions 3.86, 95%
CI 2.73 to 4.98; see supplementary Figs 5 and 6, http://
links.lww.com/HJH/A580).
Theoretical basis for intervention included in paper
Three of the studies outlined a theoretical basis for their
intervention. Orsma et al. used the Information-Motivation-
Behavioral Skills Model [37]. Nolan et al. [35] used Prochas-
ka’s trans-theoretical model to assess readiness to change
[38]. Bennett et al. [29] used theory-based principles from
the Harvard Cancer Prevention Project, which developed a
conceptual framework that articulates pathways by which
social context may influence health behaviours [39].
No significant difference was found for SBP when compar-
ing those interventions which included a theoretical
basis (3.02, 95% CI 0.79 to 5.24) vs. no theoretical
basis (4.41, 95% CI 2.26 to 5.5), but theoretical basis
recorded no reduction for DBP (no theoretical basis 0.90,
95% CI 0.02 to 1.82), whereas a significant fall was found
for no theoretical basis (3.94, 95% CI 2.53 to 5.36; see
supplementary Figs 7 and 8, http://links.lww.com/HJH/
A580).
Digital interventions in adults with hypertension
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Description of the study population
Characteristics of the included studies are shown in Table 1.
Authors differed inhow theydefinedhypertension,withYoo
et al. [33] using diagnosis by physician 1 year previously and
Bennett et al. [29,30] using use of one or more hypertensive
medication as a definition. All the remaining studies used
blood pressure levels as a definition, but these differed for
SBP, from above 160mmHg to above 140mmHg.
The interventions differed considerably in both their
clinical and population characteristics. Mean SBP at base-
line ranged from 128.5mmHg [29] to 169.5mmHg [31], and
77.4mmHg [29] to 88.5mmHg [36] for DBP. Mean age
of participants also differed considerably from 54.4 [30]
to 77 [31] years.
Men were the majority of participants in just two of the
studies [33,36], with differences in the percentage of men
ranging from 64.8 [33] to 21.0% [31]. Only two studies
recorded the ethnicity of the participants [29,31]. The
method of recording makes comparison difficult, but
Bennett et al. [29] recorded that 71.7% of their intervention
group were non-Hispanic black compared to Friedman
et al. [31], who had a black population of only 10%. All
reviews provided information on education levels with the
exception of Nolan et al. [35], who reported levels of
household income.
Outcomes
Blood pressure
Watson et al. [32] did not provide mean changes in either
SBP or DBP for those defined as having hypertension so
was excluded from the meta-analysis. They reported that in
comparing intervention and control patients with hyper-
tension, there was no difference in the percentage of
patients who reported either a greater than 10% decline
or any decline in SBP, but a significantly higher number of
intervention patients did report both a greater than 10%
decline in/or any decline for DBP [32].
In total, there were 610 intervention and 677 control
patients used in the meta-analysis for SBP. Nolan et al. [35]
divided intervention patients by use of the intervention, so
we averaged the difference between these groups weight-
ing by the numbers in each group and included in the
analysis. Figure 2 shows that overall, IDIs significantly
reduced SBP with weighted mean difference overall being
3.74mmHg (95% CI 2.19 to 2.58) with no heterogen-
eity observed (I-squared¼ 0.0%, P¼ 0.990). No significant
difference was found between those studies which
included self-monitoring and those that did not.
Piette et al. [34] did not report figures for DBP, so
included numbers were reduced to 521 for intervention
patients and 585 for control patients. Figure 3 shows
that overall for DBP considerable heterogeneity was
recorded (I-squared¼ 80.1%, P¼<0.001), with a signifi-
cant reduction in DBP of 2.37 (95% CI 0.40 to 4.35%).
However, when divided into self-monitoring vs. no self-
monitoring amuch higher reduction was recorded for those
studies with self-monitoring (4.02, 95% CI2.93 to5.12)
compared to no self-monitoring (0.88, 95% CI 0.05 to
1.80), with no heterogeneity found for either group.
Other clinical outcomes
The included studies also reported on a number of
additional clinical indicators. Two studies reported a
reduction in weight [29,36], with one finding no significant
difference [33]. Yoo et al. reported significant improve-
ments in HbA1C, total cholesterol, low-density lipoprotein
cholesterol and triglyceride levels in the intervention group,
but no analysis was undertaken on whether the difference
for the changes between intervention and control was
statistically significant [33]. Orsma et al. found that inter-
vention participants achieved, compared with controls and
controlling for baseline, a significantly greater mean
reduction in HbA1c of 0.40 vs. 0.036% [36]. Nolan et al.
reported greater significant reduction in the intervention
group for pulse pressure (6.1mmHg vs. 3.1mmHg) and
total cholesterol (0.24 vs. 0.05mmol/l) for those receiving
eight or more e-mails, but significant differences were
found for those receiving 1–7 e-mails [35]. No study
reported on changes in numbers of additional morbidities.
Behavioural
Three studies examined changes in medication adherence/
problems, all using different methods of measurement.
Bennett et al. [29] used the Hill-Bone Compliance to
Hypertension Therapy Scale [40] to assess medication
adherence. They found that intervention participants
showed significantly greater change in medication adher-
ence at months 6 and 12, but not at 24 months. Friedman
et al. [31] assessed medication adherence using home pill
count audit conducted by the field technicians, based on
Haynes’ protocol [41]. In the study by Friedman et al. [31],
mean adherence improved 17.7% in the intervention group
and 11.7% for usual care control participants (Table 2).
Piette et al. [34] measured medication-related problems
using a 7-item index with yes/no responses and found that
intervention patients at follow-up had fewer medication-
related problems (1.1, 95% CI 1.7, 0.5), such as
uncertainty as to whether their medication is important,
worry about the long-term effects of their medication or
confusion due to the complexity of the regimen.
Affective
The study by Piette et al. [34] was the only one to assess
impact of the intervention on mental health using a vali-
dated Spanish version of the 10-item Center for Epidemio-
logical Studies-Depression Scale. They found that
compared with controls, intervention patients at follow-
up had lower depression scores (2.5).
Cognitive
The study by Piette et al. [34] was also the only one to report
on changes in satisfaction with healthcare and with health
services related to their hypertension. They found that
participants in the intervention group reported a greater
overall increase in satisfaction with care and satisfaction
with care specifically related to their hypertension.
Economic
Only one study assessed cost effectiveness; Friedman et al.
[31] determined the cost effectiveness of their intervention
McLean et al.
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by calculating the expected operating costs of clinical
practice based on the experience during the study, consid-
ering all computer and telecommunication costs, facility
charges, supplies and support personnel for start-up and
maintenance of the system. Cost effectiveness ratios were
computed for medication adherence improvement and
DBP decrease using simple linear regression analysis.
The computed cost per patient user for 6 months of use
was $32.50. The cost effectiveness ratio for adherence
change after 6 months of telephone-linked computer
system use in all hypertensive patients in the study was
$5.42 per 1% improvement in adherence. For DBP, the
cost effectiveness ratio for all hypertensive patients was
$7.39 per 1 Hg decrease after 6 months of intervention use.
Costs were lower for non-adherent participants.
Quality appraisal
Details of the quality appraisal of the included studies can
be found in Table 2. All of the included studies were
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FIGURE 2 Forest plot of the effect of digital intervention on SBP reduction, comparing studies using self-monitoring and studies using no self-monitoring. Squares indicate
the effect size of a study, with 95% confidence interval (CI); diamonds indicate the overall effect size of all studies combined. (b) Funnel plot for SBP.
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RCTs, but the only study in which allocation concealment
was undertaken was found to have an inadequate
randomization procedure [35]. Three of the included
studies were unclear on how the randomization
procedure took place [29,31,33]. One study had a
dropout rate greater than 20% [35] and the eligibility
criteria were not clear (so that information had to be
requested from the authors) [33]. Three of the studies did
not control for any potential confounders in their
analysis [33,34]. The majority of the studies were also
relatively small in size, meaning that even for blood
pressure outcomes some were likely to be under-
powered (Tables 3 and 4).
DISCUSSION
This systematic review and meta-analysis of seven random-
ized controlled clinical trials found that the use of IDIs
resulted in better blood pressure control, significantly
reducing SBP by 3.74mmHg and DBP by 2.2mmHg, com-
pared to usual care. However, the strength of the evidence
is limited due to the small number of studies included,
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FIGURE 3 Forest plot of the effect of digital intervention on DBP reduction, comparing studies using self-monitoring and studies using no self-monitoring. Squares indicate
the effect size with 95% confidence interval (CI) of a study; diamonds indicate the overall effect size of all studies combined. (b) Funnel plot for DBP.
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the size of the studies and issues arising from potential bias
due to lack of allocation concealment and questions over
use of the intention-to-treat principle in a number of stud-
ies. The change in SBP and DBP is similar to that found in
previous meta-analyses, which have examined the impact
of self-monitoring vs. no self-monitoring [10,18], as well as
the impact of face-to-face lifestyle counselling [42,43]. The
change in SBP and DBP found in this study is also similar to
that found in analysis of the effect of telemedicine on
lowering blood pressure compared to conventional means
[44–46]. However, meta-analyses of the effects of teleme-
dicine have generally suffered from high levels of hetero-
geneity, limiting the generalizability of their results and
usefulness in comparison to this study. For SBP, no signifi-
cant difference was found for those interventions which
included self-monitoring. In contrast, for DBP, a difference
was found, with interventions which included self-monitor-
ing recording a reduction of 4.0mmHg, whereas those with
no self-monitoring showed no significant difference com-
pared to usual care.
The evaluation of other specific intervention com-
ponents apart from self-monitoring was difficult due to
the smaller number of studies involved. However, unlike
previous analyses, we found no evidence that interven-
tions that lasted longer than 6 months achieved greater
blood pressure reduction than those that lasted less than
6 months [19]. Intensity of the intervention also appeared
to have little effect, with no significant difference found in
blood pressure reduction for SBP, whereas studies with
daily use recorded a smaller reduction in blood pressure
for DBP compared to interventions with less intensive
usage. We also found no evidence that interventions
which offered additional professional help achieved
greater blood pressure reduction. As interventions which
have an additional professional help component to
them are likely to be more expensive, this may have a
significant detrimental effect on the cost effectiveness of
these interventions. However, there exists little evidence
from other analysis on interventions to lower blood
pressure as to whether the effect of the intensity of an
intervention or the provision of additional professional
help is unique to these interventions. Liu et al. [19]
suggested that a priority for future trials of preventive
internet-based interventions is to design and evaluate
e-counselling protocols according to theoretically
grounded hypotheses. However, we also found no sig-
nificant difference in blood pressure reduction for SBP in
those studies which included a theoretical basis for the
intervention compared with those that did not, whereas
those with a theoretical basis failed to record a significant
TABLE 3. Description of interventions
First author
(year)
Mode of
delivery
Health
education
included Setting
Self-monitoring
of blood
pressure
Frequency
of use
Theoretical
basis included
in study Duration
Watson (2012) Website Yes Hospital and community
healthcare site
Yes At least once
a week
No 6 months
Yoo (2009) Mobile phone Yes Worksite Yes Daily No 3 months
Piette (2012) Mobile phone Yes Health clinics Yes Weekly No 6 weeks
Orsma (2013) Mobile phone Yes Health clinic Yes Daily Yes (Information-
Motivation-
Behavioural Skills
Model)
10 months
Nolan (2012) E-mail Yes Outpatient clinic No Daily: month 1;
biweekly: month 2;
monthly: months 3
and 4
Prochaska’s trans-
theoretical model
4 months
Friedman (1996) USA Phone Yes Community site (e.g.
senor sites)
Yes Weekly No 6 months
Bennett (2012) USA Website/phone Yes Community health sites No Random Yes (From the
Harvard Cancer
Prevention
Program Project)
24 months
TABLE 4. Quality appraisal for included studies
First author
(year)
Appropriate
randomization
technique
Allocation
concealment
Dropout rate
below 20%
Potential confounders
properly accounted for
Were eligibility
clear
Watson (2012) Yes No Yes No Yes
Yoo (2009) Not clear No Yes No No
Piette (2012) Yes No Yes No Yes
Orsma (2013) Yes No Yes Yes Yes
Nolan (2012) No Yes No Yes Yes
Friedman (1996) Not clear Not clear Yes Yes Yes
Bennett (2012) Not clear No Yes Yes Yes
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reduction in DBP in contrast to studies with no theoretical
basis reported. It may be that theoretically grounded
hypotheses are simply poorly described in these studies
or that other factors may play a more important part in
blood pressure reduction.
Included interventions were from a wide range of
countries (United States, Korea, Honduras and Mexico,
Canada, Finland), suggesting that IDIs were suitable for
use across a wide range of health systems. The included
interventions featured a range of differing demographics
including large differences in age range, ethnicity and sex,
which help to increase the generalizability of the findings.
The range of mean SBP at baseline was between 128.5–
169.5mmHg and 77.4–88.5mmHg for DBP, suggesting that
IDIS can also be suitable to address a wide range of
hypertensive patients.
The observed magnitude of BP reduction by IDI inter-
ventions would have a significant clinical impact at a
population level if it was sustained over time. For
example, a reduction in SBP of 3mmHg would be
expected to be associated with an 8% reduction in stroke
mortality and a 5% reduction in mortality from coronary
heart disease [3]. However, only one study lasted more
than 1 year, limiting the information about how the IDIs
perform over a longer period of time. The effect of IDIs
on other clinical outcomes is uncertain due to the low
number of studies, with none assessing the effect on
quality-of-life indicators. However, most studies showed
improvements in a wide range of other clinical outcomes,
potentially adding to the health improvements offered by
the use of IDIs. Only one study assessed the cost benefits
of its impact, making the cost effectiveness of IDI difficult
to gauge. There is also no evidence on how intervention
effects may differ by socio-economic status or ethnicity.
Nevertheless, in addition to the positive clinical effects
found for IDIs, the criteria used for this study of these
interventions, not requiring delivery by a health pro-
fessional, suggest they could have additional benefits
in terms of the time and costs saved for health pro-
fessionals. The review has a number of limitations. Only
a small number of studies fulfilled the criteria, and the
majority were of average quality, had a limited time span
and were relatively small in size, meaning that even for
blood pressure outcomes most individual studies were
likely to be under-powered. The small number of studies
also meant analysis of the possible effects of specific
intervention components was limited. No studies
assessed the impact on quality of life, and information
on cost effectiveness was limited to one study. Infor-
mation on other clinical outcomes was lacking. One study
divided intervention patients by use of intervention
and did not provide data for all intervention patients;
therefore we averaged the changes in these groups,
which may over or under-report the mean change in
SBP and DBP in this study. Three further studies
[31,32,34] did not indicate that the outcome analysis
was based on an intention-to-treat principle, and this
raised the possibility of bias in the reported results.
However, as all studies reported the effect of an inter-
vention vs. no intervention, it was decided that these
studies should remain in the analysis. Strengths of the
study include the fact that for SBP, all studies showed a
consistent outcome with no heterogeneity found. The
included studies came from a wide range of different
countries with large contrasts found in the demographic
and clinical characteristics of the populations, suggesting
a wide generalizability of the findings.
In conclusion, IDIs can lower both SBP and DBP com-
pared to usual care. Results suggest these findings can be
applied to a wide range of healthcare systems and popu-
lations. However, sustainability, long-term clinical effec-
tiveness and the ‘active components’ of these interventions
remain uncertain. In our view, the evidence is not yet robust
enough to warrant a change in practice or policy. However,
if individual patients wish to use an appropriate IDI,
clinicians can feel reassured that the impact is likely to
be beneficial.
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Reviewers’ Summary Evaluations
Reviewer 1
This meta-analysis of randomized controlled trials well
documents that digital interventions used to support self-
management of hypertension are effective in reducing
blood pressure compared to usual care. This result adds
to previous evidence of e-health interventions. A large
heterogeneity of the effects was observed, likely related
to differences in study settings, duration, design, technol-
ogies, etc. Unfortunately, it was not possible to systemati-
cally report on additional outcomes (e.g. weight, metabolic
parameters, quality of life, comorbidities, adherence to
treatment, etc.) because these data were not available for
all studies. Future studies should address more in-depth
secondary effects of such an approach.
Reviewer 2
The meta-analysis elucidate the evidence for using inter-
active digital Interventions (IDIs) to support patient self-
management of hypertension.
Only few – seven!-studies qualified for inclusion , with a
wide range of methods in all aspects of intervention/
self monitoring.
Many of the studies included in the meta-analysis have
weaknesses. The authors struggle in extracting all the useful
information, and try to define the kind of selfmonitoring
with the greatest impact on outcome, but they can hardly
define the key, essential tools.
The paper is important for designing further studies on
self monitoring of hypertension.
McLean et al.
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